Concerns and clarifications regarding the article 'Virological, weight, and drug resistance outcomes among patients initiating a dolutegravir-based first line ART regimen in Zimbabwe'. Karabay O. AIDS 2024;38:1273.

Read + Share

Amedeo Smart

Independent Medical Education